375 related articles for article (PubMed ID: 20167792)
1. Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG.
Leide-Svegborn S
Radiat Prot Dosimetry; 2010; 139(1-3):208-13. PubMed ID: 20167792
[TBL] [Abstract][Full Text] [Related]
2. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.
Brix G; Lechel U; Glatting G; Ziegler SI; Münzing W; Müller SP; Beyer T
J Nucl Med; 2005 Apr; 46(4):608-13. PubMed ID: 15809483
[TBL] [Abstract][Full Text] [Related]
3. Technologist radiation exposure in routine clinical practice with 18F-FDG PET.
Guillet B; Quentin P; Waultier S; Bourrelly M; Pisano P; Mundler O
J Nucl Med Technol; 2005 Sep; 33(3):175-9. PubMed ID: 16145226
[TBL] [Abstract][Full Text] [Related]
4. Doses to nuclear technicians in a dedicated PET/CT centre utilising 18F fluorodeoxyglucose (FDG).
Seierstad T; Stranden E; Bjering K; Evensen M; Holt A; Michalsen HM; Wetteland O
Radiat Prot Dosimetry; 2007; 123(2):246-9. PubMed ID: 16987913
[TBL] [Abstract][Full Text] [Related]
5. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
Zanzonico P; Dauer L; St Germain J
Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
[TBL] [Abstract][Full Text] [Related]
6. The determination of patient dose from (18)F-FDG PET/CT examination.
Khamwan K; Krisanachinda A; Pasawang P
Radiat Prot Dosimetry; 2010 Sep; 141(1):50-5. PubMed ID: 20400773
[TBL] [Abstract][Full Text] [Related]
7. Radiation safety with positron emission tomography and computed tomography.
Devine CE; Mawlawi O
Semin Ultrasound CT MR; 2010 Feb; 31(1):39-45. PubMed ID: 20102694
[TBL] [Abstract][Full Text] [Related]
8. [Investigations of radiation exposure of the medical personnel during F-18-FDG PET studies].
Linemann H; Will E; Beuthien-Baumann B
Nuklearmedizin; 2000; 39(3):77-81. PubMed ID: 10834195
[TBL] [Abstract][Full Text] [Related]
9. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
10. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS
J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
12. Occupational per-patient radiation dose from a conservative protocol for veterinary (18) F-fluorodeoxyglucose positron emission tomography.
Martinez NE; Kraft SL; Gibbons DS; Arceneaux BK; Stewart JA; Mama KR; Johnson TE
Vet Radiol Ultrasound; 2012; 53(5):591-7. PubMed ID: 22703227
[TBL] [Abstract][Full Text] [Related]
13. Weight-based, low-dose pediatric whole-body PET/CT protocols.
Alessio AM; Kinahan PE; Manchanda V; Ghioni V; Aldape L; Parisi MT
J Nucl Med; 2009 Oct; 50(10):1570-7. PubMed ID: 19793734
[TBL] [Abstract][Full Text] [Related]
14. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
15. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
16. National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011.
Etard C; Celier D; Roch P; Aubert B
Radiat Prot Dosimetry; 2012 Dec; 152(4):334-8. PubMed ID: 22586156
[TBL] [Abstract][Full Text] [Related]
17. Radiation protection for accompanying person and radiation workers in PET/CT.
Demir M; Demir B; Sayman H; Sager S; Sabbir Ahmed A; Uslu I
Radiat Prot Dosimetry; 2011 Nov; 147(4):528-32. PubMed ID: 21183551
[TBL] [Abstract][Full Text] [Related]
18. 18F protection issues: human and gamma-camera considerations.
Cao Z; Corley JH; Allison J
J Nucl Med Technol; 2003 Dec; 31(4):210-5. PubMed ID: 14657287
[TBL] [Abstract][Full Text] [Related]
19. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
[TBL] [Abstract][Full Text] [Related]
20. The introduction of automated dispensing and injection during PET procedures: a step in the optimisation of extremity doses and whole-body doses of nuclear medicine staff.
Covens P; Berus D; Vanhavere F; Caveliers V
Radiat Prot Dosimetry; 2010 Aug; 140(3):250-8. PubMed ID: 20335185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
